XORTX Therapeutics (XRTX) Share-based Compensation (2020 - 2026)
XORTX Therapeutics (XRTX) reported Share-based Compensation of $2,133 for the quarter ended Jun 30, 2026, down 69.3% from $6,945 a year earlier and down 72.7% from the prior quarter.
Powered by 
Analysis
XORTX Therapeutics (XRTX) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, XORTX Therapeutics' Share-based Compensation came in at $19,190, down 53.5% year-over-year; for the year ended Dec 31, 2025, it was $25,155, down 79.5% from the prior year.
- Share-based Compensation has a five-year compound annual growth rate of -35.1% (years ended Dec 2020 to Dec 2025).
- By year, Share-based Compensation came in at $122,527 in the year ended Dec 31, 2024 (+1.3%), $120,984 in the year ended Dec 31, 2023 (-75.2%), $487,940 in the year ended Dec 31, 2022 (+23.1%) and $396,423 in the year ended Dec 31, 2021 (+81.0%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Share-based Compensation in data going back to the quarter ended Dec 31, 2020.
- Year over year, Share-based Compensation has now declined in each of the last eight quarters, with an average decline of 58.5% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was the quarter ended Jun 30, 2022 (growth of 353.0%); the low point was the quarter ended Jun 30, 2023 (a decline of 90.8%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $7,816 (quarter ended Mar 31, 2026), $4,124 (quarter ended Dec 31, 2025) and $5,117 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | XORTX Therapeutics | 1.62 Mn | -1.68 Mn | - | 2,133.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,133.00 |
| Mar 31, 2026 | 7,816.00 |
| Dec 31, 2025 | 4,124.00 |
| Sep 30, 2025 | 5,117.00 |
| Jun 30, 2025 | 6,945.00 |
| Mar 31, 2025 | 8,969.00 |
| Dec 31, 2024 | 9,505.00 |
| Sep 30, 2024 | 15,857.00 |
| Jun 30, 2024 | 44,031.00 |
| Mar 31, 2024 | 53,134.00 |
| Dec 31, 2023 | 28,815.00 |
| Sep 30, 2023 | 21,850.00 |
| Jun 30, 2023 | 30,769.00 |
| Mar 31, 2023 | 39,550.00 |
| Dec 31, 2022 | 70,905.45 |
| Sep 30, 2022 | 19,281.37 |
| Jun 30, 2022 | 333,311.84 |
| Mar 31, 2022 | 68,049.62 |
| Dec 31, 2021 | 113,840.55 |
| Sep 30, 2021 | 49,428.94 |
API Access
XORTX Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();